ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007